Skip to main content
Erschienen in: Journal of Bone and Mineral Metabolism 1/2020

13.08.2019 | Original Article

Impact of fracture characteristics and disease-specific complications on health-related quality of life in osteogenesis imperfecta

verfasst von: Masaki Matsushita, Kenichi Mishima, Satoshi Yamashita, Nobuhiko Haga, Sayaka Fujiwara, Keiichi Ozono, Takuo Kubota, Taichi Kitaoka, Naoki Ishiguro, Hiroshi Kitoh

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Osteogenesis imperfecta (OI) is a connective tissue disease with bone fragility. Several studies have indicated that physical function in adult OI was correlated to the disease severity, but there have been no reports delineating the impact of the fracture characteristics and disease-specific complications on health-related quality of life (HRQoL). The purpose of this study is to clarify the factors impacted on HRQoL in adult OI patients. We conducted a cross-sectional study between July 2016 and March 2018 and sent a questionnaire regarding HRQoL using Short Form-36 (SF-36) to the OI patients at the age of 20 years or older who had a medical history of the investigators’ institutions. The 40 patients completely answered the SF-36. Mental component summary and role/social component summary were unremarkable. Physical component summary (PCS) was significantly associated with z-score for height, teeth abnormality, and cardiopulmonary insufficiency (partial regression coefficient, 3.04, − 9.70, and − 11.35; p, < 0.001, 0.047, and 0.025, respectively). PCS was also significantly lower in the patients who had an initial fracture before the age of 2 years than those without occurrence of fractures until 2 years old (25.80 ± 17.15 versus 44.20 ± 16.54; p = 0.002), or those who had lower extremity fractures more than five times as compared with normal populations. Physical function was decreased in OI patients who had fractures before 2 years old, especially in lower extremity. Appropriate medical managements for cardiopulmonary insufficiency are required not only to maintain physical function but also to decrease mortality.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Andersen PE Jr, Hauge M (1989) Osteogenesis imperfecta: a genetic, radiological, and epidemiological study. Clin Genet 36:250–255CrossRef Andersen PE Jr, Hauge M (1989) Osteogenesis imperfecta: a genetic, radiological, and epidemiological study. Clin Genet 36:250–255CrossRef
2.
Zurück zum Zitat Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16:101–116CrossRef Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16:101–116CrossRef
5.
Zurück zum Zitat Chevrel G, Meunier PJ (2001) Osteogenesis imperfecta: lifelong management is imperative and feasible. Jt Bone Spine 68:125–129CrossRef Chevrel G, Meunier PJ (2001) Osteogenesis imperfecta: lifelong management is imperative and feasible. Jt Bone Spine 68:125–129CrossRef
8.
Zurück zum Zitat Pillion JP, Shapiro J (2008) Audiological findings in osteogenesis imperfecta. J Am Acad Audiol 19:595–601CrossRef Pillion JP, Shapiro J (2008) Audiological findings in osteogenesis imperfecta. J Am Acad Audiol 19:595–601CrossRef
13.
Zurück zum Zitat Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483CrossRef Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483CrossRef
16.
Zurück zum Zitat Fukuhara S, Ware JE Jr, Kosinski M, Wada S, Gandek B (1998) Psychometric and clinical tests of validity of the Japanese SF-36 health survey. J Clin Epidemiol 51:1045–1053CrossRef Fukuhara S, Ware JE Jr, Kosinski M, Wada S, Gandek B (1998) Psychometric and clinical tests of validity of the Japanese SF-36 health survey. J Clin Epidemiol 51:1045–1053CrossRef
17.
Zurück zum Zitat Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K (1998) Translation, adaptation, and validation of the SF-36 health survey for use in Japan. J Clin Epidemiol 51:1037–1044CrossRef Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K (1998) Translation, adaptation, and validation of the SF-36 health survey for use in Japan. J Clin Epidemiol 51:1037–1044CrossRef
21.
Zurück zum Zitat Malmgren B, Norgren S (2002) Dental aberrations in children and adolescents with osteogenesis imperfecta. Acta Odontol Scand 60:65–71CrossRef Malmgren B, Norgren S (2002) Dental aberrations in children and adolescents with osteogenesis imperfecta. Acta Odontol Scand 60:65–71CrossRef
22.
Zurück zum Zitat Singer RB, Ogston SA, Paterson CR (2001) Mortality in various types of osteogenesis imperfecta. J Insur Med 33:216–220PubMed Singer RB, Ogston SA, Paterson CR (2001) Mortality in various types of osteogenesis imperfecta. J Insur Med 33:216–220PubMed
23.
Zurück zum Zitat McAllion SJ, Paterson CR (1996) Causes of death in osteogenesis imperfecta. J Clin Pathol 49:627–630CrossRef McAllion SJ, Paterson CR (1996) Causes of death in osteogenesis imperfecta. J Clin Pathol 49:627–630CrossRef
25.
Zurück zum Zitat Criscitiello MG, Ronan JA Jr, Besterman EM, Schoehwetter W (1965) Cardiovascular abnormalities in osteogenesis imperfecta. Circulation 31:255–262CrossRef Criscitiello MG, Ronan JA Jr, Besterman EM, Schoehwetter W (1965) Cardiovascular abnormalities in osteogenesis imperfecta. Circulation 31:255–262CrossRef
26.
Zurück zum Zitat Stein D, Kloster FE (1977) Valvular heart disease in osteogenesis imperfecta. Am Heart J 94:637–641CrossRef Stein D, Kloster FE (1977) Valvular heart disease in osteogenesis imperfecta. Am Heart J 94:637–641CrossRef
28.
Zurück zum Zitat White NJ, Winearls CG, Smith R (1983) Cardiovascular abnormalities in osteogenesis imperfecta. Am Heart J 106:1416–1420CrossRef White NJ, Winearls CG, Smith R (1983) Cardiovascular abnormalities in osteogenesis imperfecta. Am Heart J 106:1416–1420CrossRef
29.
Zurück zum Zitat Kalath S, Tsipouras P, Silver FH (1987) Increased aortic root stiffness associated with osteogenesis imperfecta. Ann Biomed Eng 15:91–99CrossRef Kalath S, Tsipouras P, Silver FH (1987) Increased aortic root stiffness associated with osteogenesis imperfecta. Ann Biomed Eng 15:91–99CrossRef
30.
Zurück zum Zitat Hortop J, Tsipouras P, Hanley JA, Maron BJ, Shapiro JR (1986) Cardiovascular involvement in osteogenesis imperfecta. Circulation 73:54–61CrossRef Hortop J, Tsipouras P, Hanley JA, Maron BJ, Shapiro JR (1986) Cardiovascular involvement in osteogenesis imperfecta. Circulation 73:54–61CrossRef
31.
Zurück zum Zitat Thiele F, Cohrs CM, Flor A, Lisse TS, Przemeck GK, Horsch M, Schrewe A, Gailus-Durner V, Ivandic B, Katus HA, Wurst W, Reisenberg C, Chaney H, Fuchs H, Hans W, Beckers J, Marini JC, Hrabe de Angelis M (2012) Cardiopulmonary dysfunction in the osteogenesis imperfecta mouse model Aga2 and human patients are caused by bone-independent mechanisms. Hum Mol Genet 21:3535–3545. https://doi.org/10.1093/hmg/dds183 CrossRefPubMedPubMedCentral Thiele F, Cohrs CM, Flor A, Lisse TS, Przemeck GK, Horsch M, Schrewe A, Gailus-Durner V, Ivandic B, Katus HA, Wurst W, Reisenberg C, Chaney H, Fuchs H, Hans W, Beckers J, Marini JC, Hrabe de Angelis M (2012) Cardiopulmonary dysfunction in the osteogenesis imperfecta mouse model Aga2 and human patients are caused by bone-independent mechanisms. Hum Mol Genet 21:3535–3545. https://​doi.​org/​10.​1093/​hmg/​dds183 CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Letocha AD, Cintas HL, Troendle JF, Reynolds JC, Cann CE, Chernoff EJ, Hill SC, Gerber LH, Marini JC (2005) Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement. J Bone Miner Res 20:977–986. https://doi.org/10.1359/JBMR.050109 CrossRefPubMed Letocha AD, Cintas HL, Troendle JF, Reynolds JC, Cann CE, Chernoff EJ, Hill SC, Gerber LH, Marini JC (2005) Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement. J Bone Miner Res 20:977–986. https://​doi.​org/​10.​1359/​JBMR.​050109 CrossRefPubMed
35.
Zurück zum Zitat Palomo T, Fassier F, Ouellet J, Sato A, Montpetit K, Glorieux FH, Rauch F (2015) Intravenous bisphosphonate therapy of young children with osteogenesis imperfecta: skeletal findings during follow up throughout the growing years. J Bone Miner Res 30:2150–2157. https://doi.org/10.1002/jbmr.2567 CrossRefPubMed Palomo T, Fassier F, Ouellet J, Sato A, Montpetit K, Glorieux FH, Rauch F (2015) Intravenous bisphosphonate therapy of young children with osteogenesis imperfecta: skeletal findings during follow up throughout the growing years. J Bone Miner Res 30:2150–2157. https://​doi.​org/​10.​1002/​jbmr.​2567 CrossRefPubMed
Metadaten
Titel
Impact of fracture characteristics and disease-specific complications on health-related quality of life in osteogenesis imperfecta
verfasst von
Masaki Matsushita
Kenichi Mishima
Satoshi Yamashita
Nobuhiko Haga
Sayaka Fujiwara
Keiichi Ozono
Takuo Kubota
Taichi Kitaoka
Naoki Ishiguro
Hiroshi Kitoh
Publikationsdatum
13.08.2019
Verlag
Springer Japan
Erschienen in
Journal of Bone and Mineral Metabolism / Ausgabe 1/2020
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-019-01033-9

Weitere Artikel der Ausgabe 1/2020

Journal of Bone and Mineral Metabolism 1/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.